Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000440478 | SCV000528602 | likely benign | not specified | 2016-06-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV001184553 | SCV001350562 | likely benign | Cardiomyopathy | 2019-01-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002525425 | SCV001668485 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-12-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002393015 | SCV002700358 | uncertain significance | Cardiovascular phenotype | 2022-05-02 | criteria provided, single submitter | clinical testing | The c.14136C>A variant (also known as p.V4712V), located in coding exon 98 of the RYR2 gene. This variant results from a C to A substitution at nucleotide position 14136. This nucleotide substitution does not change the valine at codon 4712. This nucleotide position is poorly conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
All of Us Research Program, |
RCV004000462 | SCV004822250 | likely benign | Catecholaminergic polymorphic ventricular tachycardia | 2023-12-01 | criteria provided, single submitter | clinical testing |